American Journal of Epidemiology Practice of Epidemiology Adjusting for Partial Verification or Workup Bias in Meta-analyses of Diagnostic Accuracy Studies
暂无分享,去创建一个
Johannes B Reitsma | Joris A H de Groot | Patrick M M Bossuyt | Nandini Dendukuri | James Brophy | Kristel J M Janssen | Karel G M Moons | L. Joseph | P. Bossuyt | J. Reitsma | J. Brophy | N. Dendukuri | K. Moons | J. D. de Groot | K. Janssen | Lawrence Joseph
[1] M. Dowsett,et al. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres , 2003, The Journal of pathology.
[2] M. Untch,et al. Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] K J M Janssen,et al. Multiple imputation to correct for partial verification bias revisited , 2008, Statistics in medicine.
[4] A. O'Grady,et al. HER2 Positivity in Breast Carcinoma: A Comparison of Chromogenic In Situ Hybridization With Fluorescence In Situ Hybridization in Tissue Microarrays, With Targeted Evaluation of Intratumoral Heterogeneity by In Situ Hybridization , 2005, Applied immunohistochemistry & molecular morphology : AIMM.
[5] S D Walter,et al. Meta-analysis of diagnostic tests with imperfect reference standards. , 1999, Journal of clinical epidemiology.
[6] M. Koelemay,et al. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. , 2009, JAMA.
[7] Johannes B Reitsma,et al. Evidence of bias and variation in diagnostic accuracy studies , 2006, Canadian Medical Association Journal.
[8] E D Hsi,et al. Guidelines for HER2 testing in the UK , 2004, Journal of Clinical Pathology.
[9] M. Weinstein,et al. ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment. , 1994, Environmental health perspectives.
[10] R A Greenes,et al. Assessment of diagnostic tests when disease verification is subject to selection bias. , 1983, Biometrics.
[11] Thomas A Louis,et al. Random Effects Models in a Meta-Analysis of the Accuracy of Two Diagnostic Tests Without a Gold Standard , 2009, Journal of the American Statistical Association.
[12] Peter Green,et al. Markov chain Monte Carlo in Practice , 1996 .
[13] Z. Nemes,et al. Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice. , 2006, American journal of clinical pathology.
[14] L. Goldstein,et al. HER-2 testing in breast cancer using parallel tissue-based methods. , 2004, JAMA.
[15] P. Bossuyt,et al. Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.
[16] Ingram Olkin,et al. Meta-Analysis: Accuracy of Quantitative Ultrasound for Identifying Patients with Osteoporosis , 2006, Annals of Internal Medicine.
[17] C M Rutter,et al. A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations , 2001, Statistics in medicine.
[18] M. Weinstein,et al. HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Nandini Dendukuri,et al. A Bayesian approach to simultaneously adjusting for verification and reference standard bias in diagnostic test studies , 2010, Statistics in medicine.
[20] Ron Wolterbeek,et al. Author affiliations , 2011, Canadian Medical Association Journal.
[21] J. Beneke,et al. HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTest and PathVysion commercial assays. , 2002, American journal of clinical pathology.
[22] A. Feinstein,et al. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. , 1978, The New England journal of medicine.
[23] C. Gatsonis,et al. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. , 2006, AJR. American journal of roentgenology.
[24] Patrick Bossuyt,et al. Systematic Reviews of Diagnostic Test Accuracy , 2008, Annals of Internal Medicine.
[25] O. Hoekstra,et al. Systematic review of the diagnostic accuracy of 18F‐fluorodeoxyglucose positron emission tomography in melanoma patients , 2001 .
[26] Jinha M. Park,et al. Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] A. Zwinderman,et al. Correcting for partial verification bias: a comparison of methods. , 2011, Annals of epidemiology.
[28] N. Sneige,et al. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. , 2000, American journal of clinical pathology.
[29] References , 1971 .
[30] W. Olszewski,et al. HER2 status in breast cancer determined by IHC and FISH: comparison of the results. , 2004, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[31] Mohsen Sadatsafavi,et al. A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy. , 2010, Journal of clinical epidemiology.
[32] Nandini Dendukuri,et al. Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis , 2007, Canadian Medical Association Journal.
[33] J. Hirsh,et al. Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery , 1995, Annals of Internal Medicine.
[34] Ofer Harel,et al. Multiple imputation for correcting verification bias , 2006, Statistics in medicine.
[35] D. Rubin,et al. Inference from Iterative Simulation Using Multiple Sequences , 1992 .
[36] R. Knuechel,et al. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin‐embedded breast cancer , 2005, The Journal of pathology.
[37] S. Kakar,et al. HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: comparison of results and correlation with survival. , 2000 .
[38] Peter A Kaufman,et al. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. , 2002, Journal of the National Cancer Institute.
[39] 小倉 廣之. Evaluation of HER-2 status in breast carcinoma by fluorescence in situ hybridization and immunohistochemistry , 2003 .
[40] Frederick Mosteller,et al. Guidelines for Meta-analyses Evaluating Diagnostic Tests , 1994, Annals of Internal Medicine.
[41] P. Bossuyt,et al. Sources of Variation and Bias in Studies of Diagnostic Accuracy , 2004, Annals of Internal Medicine.
[42] Jinha M. Park,et al. Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials , 2005, Clinical Cancer Research.
[43] J. R. Reeves,et al. Evaluating HER2 amplification and overexpression in breast cancer , 2001, The Journal of pathology.
[44] HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring. , 2004, American journal of clinical pathology.
[45] Johannes B Reitsma,et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. , 2005, Journal of clinical epidemiology.
[46] H. Tsuda,et al. Detection of HER‐2/neu (c‐erb B‐2) DNA amplification in primary breast carcinoma , 2001, Cancer.
[47] M. Pritz,et al. Methods for combining rates from several studies. , 1999, Statistics in medicine.
[48] L. Joseph,et al. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. , 1995, American journal of epidemiology.